Efforts by the administration under former President Donald Trump to lower prescription drug prices will not provide immediate relief to most Americans with private insurance. While...
Dublin will host a specialized training course on protein engineering for pharmaceutical biotechnology from January 21 to January 22, 2026. This initiative, announced by ResearchAndMarkets.com, aims...
The Food and Drug Administration (FDA) has unveiled a significant initiative aimed at simplifying the approval process for biosimilars, which are cheaper alternatives to biologic drugs....
